Schedule a Meeting
Download Brochure
Table of Content
Get a Price
March 2025
Principal Consultant
Reviewed By
The global maternal mental health market size is calculated at US$ 10.32 in 2024, grew to US$ 13.25 billion in 2025, and is projected to reach around US$ 126.33 billion by 2034. The market is expanding at a CAGR of 28.47% between 2025 and 2034. Rising awareness about maternal mental health among netizens is driving the maternal mental health market as more and more people are seeking medications and therapies to support women going through postpartum mental health issues.
Approximately 10% of expectant mothers and 13% of recent mothers worldwide suffer from a mental illness, mostly depression. This is significantly higher in underdeveloped nations, where it is 15.6% during pregnancy and 19.8% after giving birth. Mothers may suffer so much in extreme situations that they may even end their own lives. Approximately 20% of moms in underdeveloped nations suffer from severe depression following delivery, according to a recent meta-analysis. This prevalence statistic, which primarily comes from high-income nations, is significantly higher than the earlier ones.
These days, from conception through prenatal care, childbirth, and the postpartum phase, mental health receives the attention it deserves. Patients get education on the value of mental health and the immediate and long-term impacts it has on both the mother and the unborn child. Couple therapy, talking to close friends and family, exercising, talking to a therapist, using antidepressant medications, and de-stressing are some helpful remedies.
Significant progress is being made by AI in identifying perinatal mental health conditions, such as anxiety and postpartum depression. AI may examine data from a variety of sources, including social media activity, patient-reported outcomes, and electronic health records using machine learning algorithms. Beyond detection, digital platforms powered by AI are being created to help with early maternal mental health intervention. These platforms frequently have AI chatbots and virtual assistants who interact with new and pregnant moms, check for signs of mental health issues, and offer tailored support and services. These AI-powered solutions seek to lower care barriers by increasing the accessibility and convenience of mental health support, guaranteeing that moms get help when they need it. During the perinatal stage, this proactive approach can greatly improve mother well-being.
Rising awareness about maternal health
One major factor propelling the maternal health market is the growing awareness of maternal and fetal health. There is a rising awareness of the dangers that poor maternal health poses to both the mother and the unborn child, and maternal health is now acknowledged as a crucial component of public health. Demand for maternal health services and products that can reduce maternal mortality and enhance newborn health outcomes is rising as more people realize how important maternal and fetal health are. The establishment of policies and initiatives to enhance maternal health outcomes, as well as greater investment in maternal health research, are further results of growing awareness of maternal and fetal health.
Workforce shortage
The scarcity of mental health professionals is made worse by the particular difficulties associated with maternal mental health treatment. Many pregnant and postpartum women could not receive the proper amount of care and support if there is not a sufficient workforce, which might have a negative impact on the health of both the mother and the unborn child. The market's expansion and the general standard of care that women may receive at this crucial stage of their lives are further hampered by the scarcity, which also impacts the ability of medical centers and clinics to provide specialized maternal mental health services.
Growing research and development
Investing in research and development can help us better understand the prevalence, risk factors, and effective treatments for mental health concerns in mothers. Evidence-based techniques, individualized treatment plans, and innovative solutions enabled by continuous research may all be used to address the unique mental health needs of new and expecting moms. R&D developments can improve the efficacy and caliber of mental health therapies while also lowering stigma and increasing awareness. Prioritizing research might help the market better meet the growing need for successful and complete maternal mental health treatment.
By disease indication, the pregnancy and postpartum general anxiety segment led the maternal mental health market in 2024. Postpartum anxiety can have long-term detrimental effects, including delayed mental development in children, and is linked to reduced maternal self-confidence. Research indicates that between 11% and 21% of new moms experience postpartum anxiety. The incidence of perinatal generalized anxiety disorder (GAD) is significant, ranging from 8.5% to 10.5% during pregnancy and 4.4% to 10.8% after delivery.
By disease indication, the postpartum depression segment is estimated to grow at the fastest rate in the maternal mental health market during the predicted period. About 1 in 7 pregnant women and those in the first year following childbirth suffer with perinatal depression, a common and potentially serious mood illness. Worldwide, 6.5% to 20% of postpartum people suffer from perinatal depression. According to a meta-analysis, China had the greatest rate of prenatal depression (21.4%). By contrast, the prevalence in the United States was 8.6%, while in Japan it was 14%. For the sake of the patient's and their unborn child's health and wellbeing, perinatal depression must be identified and treated. Perinatal depression can make it difficult to provide for the kid if treatment is not received.
By therapy, the interpersonal psychotherapy (IPT) segment held the major share of the maternal mental health market in 2024. With regard to the treatment of major depressive disorder in particular, IPT is a successful transdiagnostic treatment for mental illnesses. Because it focuses on certain interpersonal characteristics linked to depression in women during the postpartum period, IPT is a successful psychotherapy treatment for perinatal depression. IPT specifically concentrates on enlisting social support to facilitate a seamless transition into parenthood. When symptoms are mild, IPT is the most effective first-line treatment for postpartum depression (PPD); when symptoms are moderate to severe, it is used in concert with antidepressant drugs.
By therapy, the antidepressants segment is expected to showcase lucrative growth in the maternal mental health market during the estimated timeframe. When used alone or in conjunction with treatment, antidepressant medications can successfully treat perinatal depression. Antidepressants function by altering the brain's synthesis or use of certain molecules related to stress or mood. Antidepressants often take 4–8 weeks to start working. Complete healing from depression is a possibility for certain individuals. As part of their healing process, others can have less symptoms.
North America dominated the maternal mental health market in 2024. This is explained by the region's increasing prevalence of mother mental health issues, such as postpartum depression and other diseases linked to stress and anxiety. The North American maternal mental health market is also anticipated to rise between 2024 and 2030 due to factors including rising regulatory approvals, expanding awareness campaigns, and frequent product releases. The continuous awareness campaigns in the United States are also helping the industry expand.
For instance,
About one in five pregnant and postpartum women in the US are impacted by the expanding maternal mental health problem that has been plaguing the country for the past ten years. Mothers around the country urgently need assistance to lead better lives and create happy families, whether they are dealing with drug use disorders or new or preexisting mental health illnesses including postpartum depression and anxiety. $10 million has been given to four community maternal mental health initiatives nationwide as part of the most recent attempt to address this epidemic. They each got about $2.5 million. These funding will help create new initiatives that will increase access to evidence-based, culturally appropriate, and timely treatments for maternal mental health and drug use disorders.
The Clinical Practice Guideline for the management of perinatal mood, anxiety, and associated disorders was developed with funding from the Government of Canada as part of its efforts to increase access to perinatal mental health care. The Canadian government announced in 2023 that three groups would get over $857,000 in financing for their maternal mental health initiatives. The Women's College Hospital received $372,000 from Health Canada to create national physician guidelines for mood disorders in perinatal care. Furthermore, the Public Health Agency of Canada awarded $206,000K to the Families Matter Society of Calgary to spearhead initiatives targeted at fostering healthy mental health and $279,000 to the Canadian Mothercraft Society to encourage stable bonding between mothers and their children.
Asia Pacific is estimated to host a significantly growing maternal mental health market during the forecast period. Because of its high birth rates and sizable population, the Asia Pacific area has a sizable maternal health market. The market is anticipated to increase significantly as a result of growing awareness, better healthcare facilities, and rising disposable incomes in several of the region's nations. With differing healthcare requirements and cultural customs around maternal health, Asia Pacific is a varied area. Language hurdles, cultural norms, and population density are a few examples of factors that might affect how healthcare is used and provided.
According to the National Bureau of Statistics (NBS), China had 9.54 million babies born in 2024, up 520,000 from 2023. In comparison to the previous year, the birth rate increased by 0.38 per thousand to 6.77 per 1,000 in 2024. The Chinese government also put in place a five-year program for women's development that successfully guaranteed the safety and health of mothers. It furthered the Action Plan for Maternal and Child Health Improvement from 2021 to 2025 and reinforced the implementation of the five maternal and baby safety systems. Maternal safety was ensured and improved maternal health care were the outcome. Compared to 2022, the maternal mortality rate decreased by 3.8 percent to 15.1 per 100,000 in 2023.
By 2023, there will be 1,438,069,596 people living in India; by 2050, that number is expected to rise by 17% to 1,679,589,259. The United Nations (UN) Sustainable Development Goals (SDGs), to which the Indian government is a signatory, set a worldwide maternal mortality ratio (MMR) objective of less than 70 deaths per 100,000 live births by 2030. The Indian government has been working on projects to raise indicators of maternal health. The past 20 years have seen significant progress in reducing avoidable maternal fatalities. Between 2000 and 2017, the number of women and girls who die each year from pregnancy and childbirth-related causes has decreased significantly, from 451,000 to 295,000, a 38 percent decrease.
Europe is expected to be significantly growing in the maternal mental health market during the forecast period. Europe boasts a sophisticated healthcare infrastructure and a well-developed maternal health sector. Maternal mortality rates are typically low in European nations, and expectant mothers may access extensive healthcare facilities. A combination of public and private healthcare providers defines the market.
A total of €12 million has been allocated by the German government to the UNFPA's Maternal and Newborn Health Fund through 2027. With this support, Germany maintains its valued collaboration with the United Nations sexual and reproductive health organization and underlines its unwavering commitment to protecting mothers and their newborns. In 2024 alone, Germany made a €3.6 million contribution to the Maternal and Newborn Health Fund as part of its promise, highlighting its importance as a key partner in tackling maternal health issues. Furthermore, Germany has demonstrated its commitment to consistent, long-term support that allows UNFPA to achieve sustainable outcomes by becoming the first donor to commit funds until 2027.
The NHS's commitment to transforming specialized perinatal mental health services to guarantee that all women who can benefit can get care was reaffirmed in the NHS Long Term Plan. Developing and implementing maternal mental health services (called maternity outreach clinics in the Long Term Plan) in all regions of the nation by 2023–2024 was one of the commitments made. The Long Term Plan's £2.3 billion investment in mental health includes increased funding to assist future perinatal mental health service initiatives.
In December 2024, we are on the verge of a revolution in mental health science, says Miranda Wolpert, head of mental health at research funder Wellcome. Treatment and preventative innovations are constantly being developed. The data is becoming better. More people are aware than before. Additionally, investors of all shades are paying close attention as poor mental health is now perceived as an economic risk rather than only a social one.
By Disease Indication
By Therapy
By Region
March 2025
March 2025
February 2025
February 2025